Canada markets close in 6 hours 7 minutes

Shin Nippon Biomedical Laboratories, Ltd. (YB3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.05+0.15 (+1.90%)
As of 08:04AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
26,450,468
25,090,903
17,748,482
15,110,548
14,561,084
Cost of Revenue
12,167,891
12,044,235
8,061,183
7,556,144
6,945,351
Gross Profit
14,282,576
13,046,668
9,687,299
7,554,403
7,615,732
Operating Expenses
Research Development
1,741,195
683,065
425,075
392,238
400,853
Selling General and Administrative
1,931,321
1,348,220
1,000,617
835,079
859,319
Total Operating Expenses
10,120,211
7,801,426
5,491,682
5,024,862
5,387,474
Operating Income or Loss
4,162,365
5,245,242
4,195,617
2,529,541
2,228,258
Interest Expense
138,783
125,060
126,646
184,860
235,012
Income Before Tax
6,974,444
7,759,612
8,183,311
4,175,563
3,062,667
Income Tax Expense
1,456,736
1,708,903
1,016,205
497,792
414,541
Income from Continuing Operations
5,517,708
6,050,709
7,167,106
3,677,771
2,648,126
Net Income
5,531,261
6,060,057
7,127,629
3,661,855
2,550,379
Net Income available to common shareholders
5,531,261
6,060,057
7,127,629
3,661,855
2,550,379
Basic EPS
110.64
145.56
171.20
87.95
61.25
Diluted EPS
110.64
145.56
171.20
87.95
61.25
Basic Average Shares
41,631
41,631
41,632
41,632
41,632
Diluted Average Shares
41,632
41,631
41,632
41,632
41,632